Literature DB >> 19226286

Anti-inflammatory activity of p-coumaryl alcohol-gamma-O-methyl ether is mediated through modulation of interferon-gamma production in Th cells.

E-S Yu1, H-J Min, K Lee, M-S Lee, J-W Nam, E-K Seo, J-H Hong, E-S Hwang.   

Abstract

BACKGROUND AND
PURPOSE: p-Coumaryl alcohol-gamma-O-methyl ether (CAME) was isolated from Alpinia galanga and shown to contain a phenylpropanoid structure similar to p-coumaryl diacetate (CDA). CDA is known to have antioxidant and anti-inflammatory activity, but the biochemical activities of CAME are unknown. Inflammation is mediated by inflammatory cytokine production, in particular, by CD4+ T helper cells (Th cells), but it is unclear whether phenylpropanoids affect cytokine production in Th cells. In this study, we decided to investigate the functions of CAME and CDA in CD4+ Th cells. EXPERIMENTAL APPROACH: Mouse CD4+ Th cells were isolated from C57BL6 mice and stimulated with an antibody against T cell receptors in the presence of phenylpropanoids. Cytokine production was measured by elisa and intracellular cytokine staining. Gene knockout mice and tetracycline-inducible transgenic mice were used to examine the molecular mechanisms of phenylpropanoids on modulation of cytokine production. KEY
RESULTS: CAME potently reduced intracellular reactive oxygen species in Th cells, as does CDA. However, although CDA was cytotoxic, CAME selectively and potently suppresses interferon-gamma (IFNgamma) production in CD4+ Th cells, without toxicity. This effect was caused by attenuated expression of the transcription factor, T-box protein expressed in T cells (T-bet), and T-bet was essential for CAME to inhibit IFNgamma production in CD4+ Th cells. CONCLUSIONS AND IMPLICATIONS: CAME selectively and substantially suppresses IFNgamma production in CD4+ Th cells by decreasing T-bet expression. As increased IFNgamma production by CD4+ Th cells can mediate inflammatory immune responses, a selective IFNgamma suppressor, such as CAME may be an effective, naturally occurring, compound for modulating inflammatory immune disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226286      PMCID: PMC2697698          DOI: 10.1111/j.1476-5381.2009.00114.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  Transcriptional regulation of Th1/Th2 polarization.

Authors:  J Rengarajan; S J Szabo; L H Glimcher
Journal:  Immunol Today       Date:  2000-10

2.  Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance).

Authors:  Tram Ngoc Ly; Makoto Shimoyamada; Koji Kato; Ryo Yamauchi
Journal:  J Agric Food Chem       Date:  2003-08-13       Impact factor: 5.279

3.  Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.

Authors:  Hisashi Matsuda; Shin Ando; Toshio Morikawa; Shinya Kataoka; Masayuki Yoshikawa
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

4.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

5.  Structure-activity relationships of (1'S)-1'-acetoxychavicol acetate, a major constituent of a southeast Asian condiment plant Languas galanga, on the inhibition of tumor-promoter-induced Epstein-Barr virus activation.

Authors:  A Murakami; K Toyota; S Ohura; K Koshimizu; H Ohigashi
Journal:  J Agric Food Chem       Date:  2000-05       Impact factor: 5.279

6.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

7.  1'-Acetoxychavicol acetate as an inhibitor of phagocytosis of macrophages.

Authors:  N Watanabe; T Kataoka; T Tajika; M Uramoto; J Magae; K Nagai
Journal:  Biosci Biotechnol Biochem       Date:  1995-08       Impact factor: 2.043

8.  Cytotoxicity, apoptosis and DNA damage induced by Alpinia galanga rhizome extract.

Authors:  P Muangnoi; M Lu; J Lee; A Thepouyporn; R Mirzayans; X C Le; M Weinfeld; S Changbumrung
Journal:  Planta Med       Date:  2007-07-05       Impact factor: 3.352

Review 9.  Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health.

Authors:  L G Korkina
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2007-04-15       Impact factor: 1.770

10.  Induction of apoptosis in human myeloid leukemic cells by 1'-acetoxychavicol acetate through a mitochondrial- and Fas-mediated dual mechanism.

Authors:  Keisuke Ito; Tomonori Nakazato; Akira Murakami; Kenji Yamato; Yoshitaka Miyakawa; Taketo Yamada; Nobumichi Hozumi; Hajime Ohigashi; Yasuo Ikeda; Masahiro Kizaki
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more
  3 in total

1.  Immunomodulatory Effects of Taiwanese Neolitsea Species on Th1 and Th2 Functionality.

Authors:  Yin-Hua Cheng; Ying-Chi Lin; Ih-Sheng Chen; Sian-De Liu; Jih-Heng Li; Chia-Chi Wang
Journal:  J Immunol Res       Date:  2017-07-11       Impact factor: 4.818

2.  Three steps in one pot: biosynthesis of 4-hydroxycinnamyl alcohols using immobilized whole cells of two genetically engineered Escherichia coli strains.

Authors:  Shuxin Liu; Jiabin Liu; Jiayin Hou; Nan Chao; Ying Gai; Xiangning Jiang
Journal:  Microb Cell Fact       Date:  2017-06-12       Impact factor: 5.328

3.  Antiproliferative activity and induction of apoptotic by ethanolic extract of Alpinia galanga rhizhome in human breast carcinoma cell line.

Authors:  Saeed Samarghandian; Mousa-Al-Reza Hadjzadeh; Jalil Tavakkol Afshari; Mohadeseh Hosseini
Journal:  BMC Complement Altern Med       Date:  2014-06-17       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.